Abstract

Parkinsonian bradykinesia and rigidity are typically associated with excessive beta band oscillations in the subthalamic nucleus. Recently another spectral peak has been identified that might be implicated in the pathophysiology of the disease: high-frequency oscillations (HFO) within the 150–400 Hz range. Beta-HFO phase-amplitude coupling (PAC) has been found to correlate with severity of motor impairment. However, the neuronal origin of HFO and its usefulness as a potential target for deep brain stimulation remain to be established. For example, it is unclear whether HFO arise from the same neural populations as beta oscillations. We intraoperatively recorded local field potentials from the subthalamic nucleus while advancing DBS electrodes in 2 mm steps from 4 mm above the surgical target point until 2 mm below, resulting in 4 recording sites. Data from 26 nuclei from 14 patients were analysed. For each trajectory, we identified the recording site with the largest spectral peak in the beta range (13–30 Hz), and the largest peak in the HFO range separately. In addition, we identified the recording site with the largest beta-HFO PAC. Recording sites with largest beta power and largest HFO power coincided in 50% of cases. In the other 50%, HFO was more likely to be detected at a more superior recording site in the target area. PAC followed more closely the site with largest HFO (45%) than beta power (27%). HFO are likely to arise from spatially close, but slightly more superior neural populations than beta oscillations. Further work is necessary to determine whether the different activities can help fine-tune deep brain stimulation targeting.

Highlights

  • The subthalamic nucleus (STN) is a prime target for deep brain stimulation (DBS) for Parkinson's disease

  • In 45% of cases largest beta power, high-frequency oscillations (HFO) power, and phaseamplitude coupling (PAC) occurred at the same recording site, which was considerably higher than the number of cases expected by chance (p < 0.001)

  • Looking only at cases where largest beta and HFO power were identified at different locations, largest PAC was identified at the same site as beta power in 27% of cases (p = 0.502) and in 45% (p = 0.094) of cases at the same site as HFO power

Read more

Summary

Introduction

The subthalamic nucleus (STN) is a prime target for deep brain stimulation (DBS) for Parkinson's disease. Local field potentials recorded post-operatively from these DBS electrodes have revealed that Parkinsonian bradykinesia and rigidity are associated with excessive beta band oscillations (Gatev et al, 2006; Hammond et al, 2007; Oswal et al, 2013). Both dopaminergic medication and DBS reduce beta band amplitude along with improvements in clinical motor scores (Kühn et al, 2006, 2008, 2009; Weinberger et al, 2006; Ray et al, 2008; Eusebio et al, 2011).

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.